Feline gastrointestinal eosinophilic sclerosing fibroplasia Flashcards
What is feline gastrointestinal eosinophilic sclerosing fibroplasia
FGESF refers to a clinical and pathological entity of unknown cause or association defined by the presence of eosinophilic mass(es), largely confined to the gastrointestinal tract and associated lymph nodes, most commonly near the pylorus or ileocolic junction
What is the prognosis for FGESF
The prognosis for affected cats is considered guarded
What is the median age for FGESF
7 years
What are the most frequent historical and physical findings
Historical findings:
- weight loss
- hyporexia
- chronic vomiting and/or diarrhea of at least 3 months’ duration
Physical findings:
- a firm, irregular, fixed abdominal mass in the cranial and/or mid-abdomen
Is there a breed predisposition
Longhaired cats and specifically the Ragdoll breed may be overrepresented
Which physical aspect of the mass is a easy mean to make a difference with other common intra-abdominal masses
The tissue is hard and often “gritty” on advancing the needle or scalpel blade due to abundant trabeculae of mature organised collagen
- this is a useful and inexpensive point of differentiation from other common intra-abdominal masses of cats, such as large cell lymphoma, mast cell neoplasia and non-scirrhous adenocarcinoma
What is the suspected cause for FGESF
It has been hypothesised that affected cats suffer from immunological dysregulation triggered by one or more factors
- the trigger might be dietary (food allergy or intolerance), dysbiosis or other predisposing factors (e.g., ingestion of ectoparasites, endoparasites, excessive ingested hair or plant material)
What is the most consistent hematological abnormality
eosinophilia
Hyperglobulinemia is the most common biochemical abnormality
What would be a strong clue for FGESF
FGESF should be considered in cats with peripheral eosinophilia and an abdominal mass, as cats with neoplasia tend to have a stress-induced eosinopenia
- paraneoplastic eosinophilia can also be seen with intra-abdominal lymphoma
What are the ultrasonnographic changes in FGESF
US changes are non-specific, consisting of solitary masses with mural thickening and loss of layering in the stomach, duodenum, jejunum or colon
What is the best treatment plan
Surgical debulking should be done first if there is partial or complete gastrointestinal obstruction
Glucocorticoids are the main useful drugs as they interfere with cytokines and other factors promoting survival of eosinophils
Antibiotics are recommended given the high percentage of lesions where bacteria have been visualised
- a combination of amoxicillin clavulanate plus metronidazole would appear to be a good empirical choice
- marbofloxacine plus metronidazole is also possible
Addition of chlorambucil or lomustine could enhance efficacy